menu search

Baxter clocks better-than-expected q4 earnings, but fy22 guidance trail street view

Baxter International Inc (NYSE: BAX) has posted Q4 revenue of $3.5 billion, beating the consensus of $3.35 billion, up 10% on a reported basis, 12% ...

February 17, 2022, 11:19 am

Baxter clocks better-than-expected q4 earnings, but fy22 guidance trail street view

Baxter International Inc (NYSE: BAX) has posted Q4 revenue of $3.5 billion, beating the consensus of $3.35 billion, up 10% on a reported basis, 12% ...

February 17, 2022, 11:19 am

Baxter clocks better-than-expected q4 earnings, but fy22 guidance trail street view

Baxter International Inc (NYSE: BAX) has posted Q4 revenue of $3.5 billion, beating the consensus of $3.35 billion, up 10% on a reported basis, 12% ...

February 17, 2022, 11:19 am

Cae clocks 94% increase in order intake for q3

CAE Inc (NYSE: CAE) reported third-quarter FY22 revenue growth of 2% year-over-year to C$848.7 million. Sales by segments: Civil Aviation Training ...

February 11, 2022, 10:11 am

Cae clocks 94% increase in order intake for q3

CAE Inc (NYSE: CAE) reported third-quarter FY22 revenue growth of 2% year-over-year to C$848.7 million. Sales by segments: Civil Aviation Training ...

February 11, 2022, 10:11 am

Cae clocks 94% increase in order intake for q3

CAE Inc (NYSE: CAE) reported third-quarter FY22 revenue growth of 2% year-over-year to C$848.7 million. Sales by segments: Civil Aviation Training ...

February 11, 2022, 10:11 am

Alnylam clocks 76% increase in q4 product sales, expects fy22 product sales of up to $1b

Alnylam Pharmaceuticals Inc's  ALNY Q4 product revenues increased 76% Y/Y to $198.5 million, primarily due to the continued global expansion of Onpa...

February 10, 2022, 12:01 pm

Alnylam clocks 76% increase in q4 product sales, expects fy22 product sales of up to $1b

Alnylam Pharmaceuticals Inc's  ALNY Q4 product revenues increased 76% Y/Y to $198.5 million, primarily due to the continued global expansion of Onpa...

February 10, 2022, 12:01 pm

Alnylam clocks 76% increase in q4 product sales, expects fy22 product sales of up to $1b

Alnylam Pharmaceuticals Inc's  ALNY Q4 product revenues increased 76% Y/Y to $198.5 million, primarily due to the continued global expansion of Onpa...

February 10, 2022, 12:01 pm

Rada electronic clocks 36% revenue growth in q4

Rada Electronic Industries Ltd RADA reported fourth-quarter FY21 sales growth of 36% year-on-year, to $31.76 million, beating the analyst consensus...

February 9, 2022, 7:41 am

Rada electronic clocks 36% revenue growth in q4

Rada Electronic Industries Ltd RADA reported fourth-quarter FY21 sales growth of 36% year-on-year, to $31.76 million, beating the analyst consensus...

February 9, 2022, 7:41 am

Rada electronic clocks 36% revenue growth in q4

Rada Electronic Industries Ltd RADA reported fourth-quarter FY21 sales growth of 36% year-on-year, to $31.76 million, beating the analyst consensus...

February 9, 2022, 7:41 am

Inspire medical clocks 70% increase in q4 sales, issues fy22 guidance ahead of consensus

Inspire Medical Systems Inc INSP generated revenue of $78.39 million in Q4, a 70% Y/Y increase, marginally beating the consensus of $78.11 million a...

February 9, 2022, 7:18 am

Inspire medical clocks 70% increase in q4 sales, issues fy22 guidance ahead of consensus

Inspire Medical Systems Inc INSP generated revenue of $78.39 million in Q4, a 70% Y/Y increase, marginally beating the consensus of $78.11 million a...

February 9, 2022, 7:18 am

Inspire medical clocks 70% increase in q4 sales, issues fy22 guidance ahead of consensus

Inspire Medical Systems Inc INSP generated revenue of $78.39 million in Q4, a 70% Y/Y increase, marginally beating the consensus of $78.11 million a...

February 9, 2022, 7:18 am

Transdigm clocks 8% sales growth in q1, misses consensus

TransDigm Group Inc  TDG reported first-quarter sales growth of 7.8% year-over-year to $1.19 billion, +8.7% on an organic basis, missing the consen...

February 8, 2022, 12:31 pm

Transdigm clocks 8% sales growth in q1, misses consensus

TransDigm Group Inc  TDG reported first-quarter sales growth of 7.8% year-over-year to $1.19 billion, +8.7% on an organic basis, missing the consen...

February 8, 2022, 12:31 pm

Transdigm clocks 8% sales growth in q1, misses consensus

TransDigm Group Inc  TDG reported first-quarter sales growth of 7.8% year-over-year to $1.19 billion, +8.7% on an organic basis, missing the consen...

February 8, 2022, 12:31 pm

Masco clocks 9% sales growth in q4; hikes dividend

Masco Corp  MAS reported fourth-quarter FY21 net sales growth of 8.7% year-over-year to $2.02 billion, beating the consensus of $1.95 billion. In l...

February 8, 2022, 10:27 am

Masco clocks 9% sales growth in q4; hikes dividend

Masco Corp  MAS reported fourth-quarter FY21 net sales growth of 8.7% year-over-year to $2.02 billion, beating the consensus of $1.95 billion. In l...

February 8, 2022, 10:27 am


Search within

Pages Search Results: